Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.62 |
| ▸ | RECQL | P46063 | 3/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | CASP1 | P29466 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.48 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.47 |
| ▸ | NT5E | P21589 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | CASP6 | P55212 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31650697 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRCYP3A4RECQLHSD17B10 | |
| SCHEMBL176866 | 0.83 | ALDH1A1 (0.57) | ALDH1A1TSHRCYP3A4RECQLHSD17B10 | |
| SCHEMBL1300150 | 0.83 | CYP3A4 (0.55) | ALDH1A1TSHRCYP3A4RECQLHSD17B10 | |
| SCHEMBL27417258 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TSHRCYP3A4RECQLHSD17B10 | |
| SCHEMBL1383117 | 0.81 | CA1 (0.55) | ALDH1A1TSHRCYP3A4RECQLHSD17B10 | |
| SCHEMBL7511717 | 0.80 | RAPGEF4 (0.56) | ALDH1A1TSHRCYP3A4RECQLHSD17B10 | |
| SCHEMBL31618992 | 0.79 | CYP3A4 (0.52) | ALDH1A1TSHRCYP3A4RECQLHSD17B10 | |
| SCHEMBL282188 | 0.79 | L3MBTL1 (0.62) | ALDH1A1TSHRCYP3A4RECQLHSD17B10 | |
| SCHEMBL30431062 | 0.79 | L3MBTL1 (0.62) | ALDH1A1TSHRCYP3A4RECQLHSD17B10 | |
| SCHEMBL1729184 | 0.78 | HSD11B1 (0.45) | TSHRHSD17B10HPGDCASP1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250107976-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR | L'OREAL (FR) | 2025-04-03 | — | — | US | claimed |
| WO-2025072691-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR | HART TAYLOR (US) | 2025-04-03 | — | — | WO | claimed |
| US-20230301892-A1 | COMPOSITIONS AND METHODS FOR ELONGATING CURLY HAIR | L'OREAL (FR) | 2023-09-28 | — | — | US | claimed |
| WO-2023154471-A2 | COMPOSITIONS AND METHODS FOR STYLING HAIR | LAGA STEPHANIE (US) | 2023-08-17 | — | — | WO | claimed |
| US-20230248629-A1 | COMPOSITIONS AND METHODS FOR STYLING HAIR | L'OREAL (FR) | 2023-08-10 | — | — | US | claimed |
| US-20220202676-A1 | COMPOSITIONS FOR ALTERING THE COLOR OF HAIR | L'OREAL (FR) | 2022-06-30 | — | — | US | claimed |
| EP-3731801-B1 | COMPOSITIONS FOR ALTERING THE COLOR OF HAIR | OREAL (FR) | 2022-03-09 | — | — | EP | claimed |
| EP-3731801-A1 | COMPOSITIONS FOR ALTERING THE COLOR OF HAIR | L'OREAL (FR) | 2020-11-04 | — | — | EP | claimed |
| US-20190201309-A1 | COMPOSITIONS FOR ALTERING THE COLOR OF HAIR | L'OREAL (FR) | 2019-07-04 | — | — | US | claimed |
| US-9556342-B2 | Zwitterionic lignin derivatives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2017-01-31 | — | — | US | claimed |
| US-20150135989-A1 | ZWITTERIONIC LIGNIN DERIVATIVES | CRESTLINE DIRECT FINANCE, L.P. | 2015-05-21 | — | — | US | claimed |
| EP-2120555-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | Heller, Adam (US) | 2009-11-25 | — | — | EP | claimed |
| WO-2008094664-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | HELLER ADAM (US) | 2008-08-07 | — | — | WO | claimed |
| EP-4719612-A1 | RINSE-OFF HAIR COSMETIC COMPOSITIONS, METHOD OF TREATING HAIR, METHOD FOR PROVIDING IMPROVED CURLS DEFINITION TO THE HAIR AND USE OF A COMPOSITION | L'OREAL (FR) | 2026-04-08 | — | — | EP | disclosed |
| EP-4704790-A1 | COMPOSITIONS FOR DYEING KERATIN FIBERS | Beautyge, S.L. (ES) | 2026-03-11 | — | — | EP | disclosed |
| WO-2026039882-A1 | METHODS FOR REDUCING COLOR FADING IN COLOR-TREATED HAIR | L'OREAL (FR) | 2026-02-26 | — | — | WO | disclosed |
| US-4055557-A | MONOAZO DYES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-10-25 | — | — | US | disclosed |
| US-4052444-A | DIAZO COUPLERS FOR MONOAZO DYES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-10-04 | — | — | US | disclosed |
| US-3966705-A | Disulfo naphthalene containing fiber-reactive tetrazo dyes | CIBA-GEIGY CORPORATION (US) | 1976-06-29 | — | — | US | disclosed |
| US-3933829-A | 4-Aminoquinoline derivatives | JOHN WYETH & BROTHER LIMITED (EN) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248629-A1 | COMPOSITIONS AND METHODS FOR STYLING HAIR | DPM1, NACA, FUT6 | ALDH1A1 4127/4885TSHR 4465/4885CYP3A4 4513/4885 |
| US-20190201309-A1 | COMPOSITIONS FOR ALTERING THE COLOR OF HAIR | TYR, SHH, AADAT | ALDH1A1 404/4885TSHR 3883/4885CYP3A4 4284/4885 |
| US-20230301892-A1 | COMPOSITIONS AND METHODS FOR ELONGATING CURLY HAIR | GLUL, NACA, SHH | ALDH1A1 2859/4885TSHR 4654/4885CYP3A4 4740/4885 |
| US-20220202676-A1 | COMPOSITIONS FOR ALTERING THE COLOR OF HAIR | TYR, SHH, AADAT | ALDH1A1 404/4885TSHR 3883/4885CYP3A4 4284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.